We could not find any results for:
Make sure your spelling is correct or try broadening your search.
uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipel... uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Show more
~ Presented promising clinical update from U.S. and European Phase I/II trials of AMT-130 in Huntingtonโs disease; Up to three years of follow-up data to be presented in mid-2024; Regulatory...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.29 | 6.15711252654 | 4.71 | 4.895 | 4.35 | 506226 | 4.65350128 | CS |
4 | -0.23 | -4.39770554493 | 5.23 | 5.4799 | 4.35 | 638758 | 4.91446571 | CS |
12 | -0.5 | -9.09090909091 | 5.5 | 6.87 | 4.35 | 966489 | 5.36791814 | CS |
26 | -0.84 | -14.3835616438 | 5.84 | 8.66 | 4.35 | 1110727 | 6.05063495 | CS |
52 | -14.46 | -74.3062692703 | 19.46 | 22.48 | 4.35 | 1054983 | 8.30618632 | CS |
156 | -29.12 | -85.3458382181 | 34.12 | 38.8 | 4.35 | 743776 | 16.06996736 | CS |
260 | -51.63 | -91.170757549 | 56.63 | 82.49 | 4.35 | 655508 | 27.67421996 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions